PORTARO, SIMONA
 Distribuzione geografica
Continente #
EU - Europa 978
NA - Nord America 925
AS - Asia 402
Totale 2.305
Nazione #
US - Stati Uniti d'America 923
IE - Irlanda 274
SE - Svezia 251
CN - Cina 222
IT - Italia 171
PL - Polonia 118
SG - Singapore 115
DE - Germania 45
FI - Finlandia 39
IN - India 30
GB - Regno Unito 23
UA - Ucraina 21
BE - Belgio 14
VN - Vietnam 14
ID - Indonesia 8
NL - Olanda 6
FR - Francia 4
AT - Austria 3
CZ - Repubblica Ceca 3
IR - Iran 3
TR - Turchia 3
CA - Canada 2
HK - Hong Kong 2
LT - Lituania 2
AM - Armenia 1
CH - Svizzera 1
ES - Italia 1
IL - Israele 1
KR - Corea 1
LK - Sri Lanka 1
PT - Portogallo 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
Totale 2.305
Città #
Dublin 273
Chandler 221
Nyköping 143
Warsaw 112
Singapore 94
Beijing 72
Messina 72
Jacksonville 68
Ashburn 67
Ann Arbor 45
Dearborn 44
New York 44
Princeton 44
Medford 37
Cambridge 27
Des Moines 24
Shenyang 21
Pune 19
Jinan 18
Wilmington 16
Dong Ket 14
Boardman 13
Brussels 12
Rome 12
Caltagirone 11
Hangzhou 11
Mascali 11
Nanjing 11
Bremen 10
Hyderabad 10
Haikou 9
Ningbo 9
San Mateo 9
Tianjin 9
Helsinki 8
Jakarta 8
Lancaster 8
Munich 8
Taizhou 8
Catania 7
Fuzhou 7
Los Angeles 6
Bydgoszcz 5
Lappeenranta 5
Seattle 5
Washington 5
Falls Church 4
Taiyuan 4
Woodbridge 4
Zhengzhou 4
Changsha 3
Hebei 3
Houston 3
Izmir 3
Jiaxing 3
Milan 3
Norwalk 3
Acireale 2
Ardabil 2
Brno 2
Frankfurt am Main 2
Guangzhou 2
Hong Kong 2
Leno 2
Nanchang 2
Paris 2
Portomaggiore 2
Salt Lake City 2
San Giuliano Milanese 2
Santa Clara 2
Sevenoaks 2
Siracusa 2
Torino 2
Waanrode 2
Atlanta 1
Augusta 1
Bitonto 1
Castricum 1
Cavriago 1
Clifton 1
Colombo 1
Dongyang 1
Edinburgh 1
Fairfield 1
Genova 1
Gibellina 1
Glasgow 1
Kirkland 1
Lausanne 1
Linda a Velha 1
London 1
Luohe 1
Montréal 1
Mumbai 1
Naples 1
Nashville 1
New Hampton 1
Newark 1
Nuremberg 1
Nürnberg 1
Totale 1.789
Nome #
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. 114
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 97
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports 88
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 84
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 82
Toward a more personalized motor function rehabilitation in myotonic dystrophy type 1: The role of neuroplasticity 77
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification 76
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 72
Force and strain during horseback riding: bridging the gap between theory and clinical practice 72
La miopatia ipotiroidea 69
Flecainide-responsive myotonia permanens with SNEL onset: A new case and literature review 64
Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. 62
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 60
null 58
Malattia di Chanarin-Dorfman: aspetti clinici, gemetici e neuroradiologici di un caso adulto seguito per 25 anni 57
Advances in assessing myotonia: Can sensor-engineered glove have a role? 57
A dental implant dislocated in the ethmoidal sinus: a case report 57
ANT1 is reduced in sporadic inclusion body myositis. 56
Chasing the chameleon: Psychogenic paraparesis responding to non-invasive brain stimulation 56
Chanarin-Dorfman disease (CDD): clinical, genetic and neuroradiological aspects in an adult case followed over 25 years 54
TRPV4 related scapuloperoneal spinal muscular atrophy: Report of an Italian family and review of the literature 54
Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype 50
Telerehabilitation in individuals with severe acquired brain injury 50
Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype 49
Tubular aggregates: do they help in diagnosing neuromuscular disorders? 48
A case of necrotizing myopathy with proximal weakness and cardiomyopathy 48
Paving the way for a better understanding of the pathophysiology of gait impairment in myotonic dystrophy: A pilot study focusing on muscle networks 47
Can muscle vibration be the future in the treatment of cerebral palsy-related drooling? A feasibility study 47
SPINALNERVE ROOT THICKENING AND ANHANCEMENT CAUSING PAINFUL AND DISABLING SYMPTOMS IN CMT 1A: FAST RECOVERY AFTER HIGH DOSAGE IVIG. 43
null 43
Deletion of the Williams Beuren syndrome critical region unmasks facioscapulohumeral muscular dystrophy 40
New versus Old Oral Anticoagulants: How can we set the Scale needle? Considerations on a Case Report 35
null 31
Telemedicine for Facio-Scapulo-Humeral Muscular Dystrophy: A multidisciplinary approach to improve quality of life and reduce hospitalization rate? 31
null 28
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population 28
null 28
null 27
The role of brain oscillations in post-stroke motor recovery: An overview 26
Prevalence study of genetically defined skeletal muscle channelopathies in England 26
Tubular aggregates: do they help in diagnosing neuromuscular disorders ? 25
Hemangiomas of the tongue and the oral cavity in a myotonic dystrophy type 1 patient: A case report 25
null 24
Long-Term Follow-Up in Infantile-Onset Lambert-Eaton Myasthenic Syndrome 21
A new explanation for recessive myotonia congenita Exon deletions and duplications in CLCN1 21
null 20
Intramuscular injections of botulinum toxin for the treatment of upper back myofascial pain syndrome: A systematic review of randomized controlled trials 19
null 18
Sporadic late-onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasone. 18
Steroid Management in a Patient with Myasthenia Gravis Undergoing COVID-19 Vaccination 16
Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach 16
A case report of recessive myotonia congenita and early onset cognitive impairment 11
Early-infantile onset epilepsy and developmental delay caused by bi-allelic GAD1 variants 1
Totale 2.426
Categoria #
all - tutte 10.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020197 0 0 0 0 0 0 20 18 4 101 36 18
2020/2021360 25 21 58 15 75 16 23 22 35 39 11 20
2021/2022341 3 37 3 9 15 6 52 17 4 75 22 98
2022/2023819 70 92 34 64 47 86 9 49 328 6 26 8
2023/2024265 20 42 9 25 19 94 8 10 0 16 5 17
2024/2025212 13 8 20 64 42 48 17 0 0 0 0 0
Totale 2.426